Obstetrics/Gynecology
RSSArticles
-
Study Reveals Low Rate of Contraceptive Use in Women with Recent Preterm Births
Medicaid claims data among a North Carolina cohort show that women were less likely to fill a contraceptive claim within 90 days after preterm birth. Investigators theorized it would be harder for women to access contraception after a preterm birth because they would be caring for a medically fragile infant. Also, women who deliver preterm experience shorter pregnancies, which means there is less time for a conversation with their healthcare providers about contraception.
-
Servicewomen Experience Barriers to Contraception
A follow-up survey of United States servicewomen and their access to contraceptives during their deployment revealed both good and bad news. Some women reported greater access to contraception, while others experienced barriers to obtaining contraceptives in the weeks leading up to their deployment.
-
Study: Copper IUDs Do Not Appear to Prevent Implantation or Increase HIV Risk
For decades, clinicians and the public assumed that copper intrauterine devices (IUDs) prevented pregnancy by preventing implantation. There also was fear that IUDs could increase a woman’s risk of HIV infection. Results of a new study suggested these assumptions are incorrect.
-
Contraceptive Implants Are an Option for Patients Taking Isotretinoin
When clinicians prescribe the acne medication isotretinoin, they advise reproductive-age women to avoid pregnancy through two different contraceptives and an online iPledge app. Since the drug causes severe birth defects, it is important young women do not become pregnant while taking the drug. Etonogestrel contraceptive implants could be one contraceptive option for women taking isotretinoin, but there are concerns the acne drug would decrease the effectiveness of hormonal contraceptives.
-
Associations and Regulators Recommend Guidelines for Reopening Clinics
The American College of Obstetricians and Gynecologists and the Infectious Diseases Society of America offered guidelines for how physician offices, clinics, and other facilities can reopen to in-person, nonessential services in the next phase of the pandemic.
-
Abortion Access Problems Arise During COVID-19 Pandemic
Some states used the COVID-19 pandemic to stop abortion clinics from operating, saying abortions were nonessential medical services. Lawsuits helped reopen some sites, but abortion access was limited.
-
Estrogen Replacement: Is Long Duration of Therapy Good for the Brain?
Longer lifetime exposure to endogenous estrogen and menopausal estrogen replacement were associated with better cognitive status in older adult women.
-
Restricting Access to Abortion Increases Complications
Restrictive abortion laws increase the chance that a woman will self-manage her abortion, a practice associated with an increased risk of complications.
-
Should Metronidazole Be Added Routinely to Treatment Regimens for PID?
In this randomized, double-blind, controlled trial, routine treatment with metronidazole compared to placebo in addition to doxycycline and ceftriaxone reduced the presence of endometrial anaerobes, Mycoplasma genitalium, and pelvic tenderness at 30 days post-treatment. However, clinical improvement at three days post-treatment was no different between the two groups.
-
COVID-19 and Pregnancy: What Obstetricians Need to Know
While data remain limited on this particular coronavirus, extrapolation from other viruses (severe acute respiratory syndrome and Middle East respiratory syndrome), and best clinical observations and expert recommendations have led to current guidelines in care.